Home World News No improvement in OS, but more grade 3 or higher AEs with... World News No improvement in OS, but more grade 3 or higher AEs with atezolizumab plus SBRT among patients with inoperable early-stage NSCLC By Ogkologos - September 24, 2026 89 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SWOG/NRG S1914 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Clinics Offering “Mammoglam” Services to Encourage More Women to Get Mammograms June 12, 2019 Darolutamide Delays the Spread of Some Prostate Cancers March 15, 2019 FDA Approves Trifluridine and Tipiracil with Bevacizumab for Previously Treated Metastatic... August 18, 2023 6 of the biggest good news cancer stories of 2021 December 15, 2021 Load more HOT NEWS 10 Ways to Brave Cancer Treatment: Tips from a Survivor Celebrating 10 years of partnership with ScottishPower and £35m raised FDA Approvals Bring New Options for Older Patients with AML Group Dressed as Breasts Gathers to Protest Facebook’s Censorship of Areola...
